All articles tagged with #aps
A 47-year-old German woman with refractory autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid syndrome was treated with CAR-T cell therapy to eradicate rogue B cells and reboot her immune system. After exhausting standard therapies, this radical approach led to dramatic improvement and is described by doctors as a landmark in immunotherapy.
A 47-year-old woman with autoimmune haemolytic anaemia (AIHA), immune thrombocytopenia (ITP) and antiphospholipid syndrome (APS) achieved rapid, lasting remission after CD19-targeted CAR-T cell therapy, effectively resetting her immune system and enabling a near-normal life; she has remained in treatment-free remission for about 14 months, while researchers note the need for trials to determine durability and wider applicability.
The Arizona Corporation Commission has approved a requested 8% rate hike for APS, which could result in a $10-12 increase per month for typical residential customers. This decision follows a surge in demand for electricity last year, leading to a 22% increase in third-quarter profit for Pinnacle West Capital Corp., the owner of APS. The rate adjustment aims to support infrastructure upgrades and provide reliable energy, with increased assistance for vulnerable customers included in the plan.
The American Physical Society has faced criticism for publishing an article in Physics Education Review that claimed the use of whiteboards was an example of "whiteness" in physics. The article generated a negative response from the physics community, prompting the APS to publish an editorial defending the article and threatening to revoke awards and disqualify candidates who violate the APS Code of Conduct. The APS and Physical Review have since rejected a Comment that critiqued the original article, claiming that scientific analysis cannot be used to critique non-scientific papers.